Pfizer: Hemorrhage trials

The registry lists 11 Hemorrhage studies with Pfizer as lead sponsor. 2 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 1Phase 3 4Phase 4 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia BRecruitingNCT05611801Phase 3
• Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B RespectivelyRecruitingNCT05568719Phase 3
• Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in KoreaCompletedNCT05022563Results posted
• Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia BCompletedNCT03938792Phase 3Results posted
• Safety and Tolerability of PF-05230907 in Intracerebral HemorrhageTerminatedNCT02687191Phase 1Results posted
• Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal SurgeryCompletedNCT00827931Phase 4Results posted
• Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone FractureCompletedNCT00824564Phase 4Results posted
• An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.CompletedNCT07527832
• High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in FranceCompletedNCT05038228
• Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageCompletedNCT00040495Phase 3
• Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageCompletedNCT00037570Phase 2